Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Joel Jakobsson
Observed names:
J Jakobsson,
J. Jakobsson
Institution:
University of Gothenburg
Observed institutions:
Uppsala University,
Sahlgrenska University Hospital,
Karolinska Institutet,
National Hospital for Neurology and Neurosurgery,
UCL Queen Square Institute of Neurology,
University College London,
University of Gothenburg
show all 7
ORCID:
0000-0002-3711-8171
Observed ORCID:
0000-0002-3711-8171
OpenAlex ID:
A5063282531
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis
2019
·
Claire Bridel
, Wessel N. van Wieringen
, et al.
·
JAMA Neurology
·
852
PDF
Apolipoprotein E Genotype and the Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers for Alzheimer Disease
2014
·
Ronald Lautner
, Sebastian Palmqvist
, et al.
·
JAMA Psychiatry
·
126
PDF
Cerebrospinal fluid metabolomics identifies a key role of isocitrate dehydrogenase in bipolar disorder: evidence in support of mitochondrial dysfunction hypothesis
2016
·
N Yoshimi
, T Futamura
, et al.
·
Molecular Psychiatry
·
123
PDF
Blood metabolomics analysis identifies abnormalities in the citric acid cycle, urea cycle, and amino acid metabolism in bipolar disorder
2016
·
Noriko Yoshimi
, Takashi Futamura
, et al.
·
BBA Clinical
·
121
PDF
Monocyte and microglial activation in patients with mood-stabilized bipolar disorder
2015
·
Joel Jakobsson
, Maria Bjerke
, et al.
·
Journal of Psychiatry and Neuroscience
·
106
PDF
Elevated Concentrations of Neurofilament Light Chain in the Cerebrospinal Fluid of Bipolar Disorder Patients
2014
·
Joel Jakobsson
, Maria Bjerke
, et al.
·
Neuropsychopharmacology
·
97
PDF
Altered Concentrations of Amyloid Precursor Protein Metabolites in the Cerebrospinal Fluid of Patients with Bipolar Disorder
2012
·
Joel Jakobsson
, Henrik Zetterberg
, et al.
·
Neuropsychopharmacology
·
89
PDF
Markers of neuroinflammation and neuronal injury in bipolar disorder: Relation to prospective clinical outcomes
2017
·
Anniella Isgren
, Carl Sellgren
, et al.
·
Brain Behavior and Immunity
·
86
PDF
Perturbation of Syndapin/PACSIN Impairs Synaptic Vesicle Recycling Evoked by Intense Stimulation
2008
·
Fredrik Andersson
, Joel Jakobsson
, et al.
·
Journal of Neuroscience
·
74
PDF
Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment
2014
·
Anniella Isgren
, Joel Jakobsson
, et al.
·
Brain Behavior and Immunity
·
72
CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairment
2015
·
Sindre Rolstad
, Joel Jakobsson
, et al.
·
European Neuropsychopharmacology
·
67
Markers of glutamate signaling in cerebrospinal fluid and serum from patients with bipolar disorder and healthy controls
2014
·
Erik Pålsson
, Joel Jakobsson
, et al.
·
European Neuropsychopharmacology
·
60
Cognitive Performance and Cerebrospinal Fluid Biomarkers of Neurodegeneration: A Study of Patients with Bipolar Disorder and Healthy Controls
2015
·
Sindre Rolstad
, Joel Jakobsson
, et al.
·
PLoS ONE
·
56
PDF
Regulation of Synaptic Vesicle Budding and Dynamin Function by an EHD ATPase
2011
·
Joel Jakobsson
, Frauke Ackermann
, et al.
·
Journal of Neuroscience
·
55
PDF
Role of epsin 1 in synaptic vesicle endocytosis
2008
·
Joel Jakobsson
, Helge Gad
, et al.
·
Proceedings of the National Academy of Sciences
·
49
Blood–cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment
2014
·
Henrik Zetterberg
, Joel Jakobsson
, et al.
·
Psychiatry Research
·
47
Improved clinical investigation and evaluation of high-risk medical devices: the rationale and objectives of CORE-MD (Coordinating Research and Evidence for Medical Devices)
2021
·
A G Fraser
, R G H H Nelissen
, et al.
·
European Heart Journal - Quality of Care and Clinical Outcomes
·
41
PDF
Targeting Synaptic Pathology with a Novel Affinity Mass Spectrometry Approach
2014
·
Ann Brinkmalm
, Gunnar Brinkmalm
, et al.
·
Molecular & Cellular Proteomics
·
34
PDF
Cerebrospinal fluid proteomics targeted for central nervous system processes in bipolar disorder
2021
·
Andreas Göteson
, Anniella Isgren
, et al.
·
Molecular Psychiatry
·
32
PDF
Low neuropeptide Y in cerebrospinal fluid in bipolar patients is associated with previous and prospective suicide attempts
2014
·
Johan V. Sandberg
, Joel Jakobsson
, et al.
·
European Neuropsychopharmacology
·
30
CACNA1Cpolymorphism and altered phosphorylation of tau in bipolar disorder
2015
·
Joel Jakobsson
, Erik Pålsson
, et al.
·
The British Journal of Psychiatry
·
25
PDF
Cerebrospinal fluid proteomic study of two bipolar disorder cohorts
2022
·
Anniella Isgren
, Andreas Göteson
, et al.
·
Molecular Psychiatry
·
22
PDF
Cerebrospinal fluid microglia and neurodegenerative markers in twins concordant and discordant for psychotic disorders
2016
·
Viktoria Johansson
, Joel Jakobsson
, et al.
·
European Archives of Psychiatry and Clinical Neuroscience
·
21
PDF
Decreased cerebrospinal fluid secretogranin II concentrations in severe forms of bipolar disorder
2013
·
Joel Jakobsson
, Mats Stridsberg
, et al.
·
Journal of Psychiatry and Neuroscience
·
20
A serum proteomic study of two case-control cohorts identifies novel biomarkers for bipolar disorder
2022
·
Andreas Göteson
, Anniella Isgren
, et al.
·
Translational Psychiatry
·
19
PDF
Show more works
View as search
Works count:
42
Citation count:
2,362
H-index:
22
I10-index:
27
Year
Topic
Type